Watchlist for April 22, 2008

See one of the recent 'Chart Reading' posts for some potential swing candidates. Also be sure to check my typical swing trade entry & exit rules.

Potential day trades:

(From Briefing.com)

Gapping Down

In reaction to disappointing earnings/guidance: OMCL -29.3% (also downgraded to Neutral at Broadpoint), BRKR -17.5% (announces foreign exchange losses in Q1 of 2008), BJS -14.6%, NFLX -13.5% (also removed from Alpha List at Piper and downgraded to Neutral at Credit Suisse), QI -13.2%, AAI -12.3% (also announces intention to offer $65 mln of Convertible Senior Notes due 2015 and to offer 14.25 mln shares of common stock), CSL -11.3%, UNH -10.1%, TLAB -8.6%, PKG -8.0%, AVY -6.4%, NVLS -5.0%, AXE -4.9%, COH -4.6%, VNUS -4.5%, CNI -4.3%, STI -3.9%, FDG -3.6%, CME -3.3%, GENZ -2.8% (announces the FDA has informed co that Myozyme produced at the 160L bioreactor scale and Myozyme produced at the 2000L scale should be classified as two products), CVTI -2.7%, USNA -2.6%, MCD -2.3%, TXN -2.3%, GNTX -1.8%... Select healthcare stocks showing weakness following UNH earnings results: CVH -4.3%, WLP -3.8%, AET -3.7%, WCG -1.4%... Select European financial names trading lower with weakness in overseas trading: RBS -3.9% (takes further write-downs, plans $23.78 bln rights issue - WSJ), BCS -3.5%, ING -2.2%, DB -1.5%... Other news: CIT -12.9% (announces concurrent offerings of common stock and convertible preferred stock, for an aggregate of $1 bln), CNB -6.5% (prices a 38 mln share common stock offering at $8/share), ALO -5.5% (to withdraw and resubmit its New Drug Application for EMBEDA)... Analyst downgrades: VNUS -4.5% (downgraded to Hold at Roth), MDTH -4.2% (downgraded to Hold at Stifel Nicolaus), SAY -3.4% (downgraded to Hold at Stifel Nicolaus), PER -1.8% (downgraded to Hold at Keybanc), AMLN -1.1% (downgraded to Underperform at BMO).

Gapping Up

In reaction to strong earnings/guidance: VLTR +12.1% (also upgraded to Outperform at Piper), ZRAN +11.2%, FOE +10.9%, WGOV +8.7%, CPO +6.4%, EAT +6.0%, JBLU +5.5%, BSX +5.1%, KCI +4.8%, MICC +4.4%, BTU +3.8%, LOGI +3.7%, NBR +3.4%, CE +3.2%, ALB +2.2%, LXK +2.0%, STLD +1.8%, T +1.6%, ARTC +1.3%, CR +1.2%, DD +1.0%, LMT +1.0%, HSC +1.0%... Other news: BMTI +10.1% (receives written communication from FDA confirming status of ongoing pivotal trial for GEM OS1), ICO +9.8% (still checking), FTEK +6.4% (Cramer makes positive comments on MadMoney), MHS +4.6% (Medco Health Solutions, UnitedHealth Group announce pharmacy services agreement; also upgraded to Buy at Jefferies and upgraded to Buy at Citigroup), TTEK +2.9% (Cramer makes positive comments on MadMoney), IFX +2.2% (prepares for disposal and deconsolidation of Qimonda; will record a write-down of euro 1 billion; FY08 EBIT guidance remains unchanged), VE +2.2% (still checking), AGU +1.4% (profiled in New America section of IBD)... Analyst upgrades: BRLC +13.2% (upgraded to Outperform at Baird), NCC +4.0% (upgraded to Buy at Deutsche Bank and upgraded to Outperform from Market Perform at Bernstein), BCSI +2.2% (upgraded to Buy at Stifel Nicolaus), LOCM +1.9% (initiated with a Buy at Morgan Joseph).

Disclaimer & How I use this list